Getinge AB (publ) (GETI-B.ST)
SEK 174.85
(2.01%)
SEK 174.85
(2.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 55.09 Billion SEK | 5.89% |
| 2022 | 52.03 Billion SEK | 16.78% |
| 2021 | 44.55 Billion SEK | -1.02% |
| 2020 | 45.01 Billion SEK | 0.67% |
| 2019 | 44.71 Billion SEK | 3.14% |
| 2018 | 43.35 Billion SEK | 2.97% |
| 2017 | 42.1 Billion SEK | -23.74% |
| 2016 | 55.21 Billion SEK | 3.71% |
| 2015 | 53.23 Billion SEK | 0.79% |
| 2014 | 52.81 Billion SEK | 19.22% |
| 2013 | 44.3 Billion SEK | 3.22% |
| 2012 | 42.92 Billion SEK | 3.5% |
| 2011 | 41.46 Billion SEK | 19.9% |
| 2010 | 34.58 Billion SEK | -7.77% |
| 2009 | 37.49 Billion SEK | 13.52% |
| 2008 | 33.03 Billion SEK | 43.67% |
| 2007 | 22.99 Billion SEK | 44.81% |
| 2006 | 15.87 Billion SEK | 9.25% |
| 2005 | 14.53 Billion SEK | 16.66% |
| 2004 | 12.45 Billion SEK | 3.53% |
| 2003 | 12.03 Billion SEK | 26.95% |
| 2002 | 9.47 Billion SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 56.32 Billion SEK | 2.22% |
| 2024 Q3 | 59.61 Billion SEK | 7.94% |
| 2024 Q2 | 55.23 Billion SEK | -1.93% |
| 2023 Q3 | 53.54 Billion SEK | 2.15% |
| 2023 Q1 | 50.98 Billion SEK | -2.01% |
| 2023 Q2 | 52.41 Billion SEK | 2.8% |
| 2023 FY | 55.09 Billion SEK | 5.89% |
| 2023 Q4 | 55.09 Billion SEK | 2.91% |
| 2022 Q2 | 48.48 Billion SEK | 6.66% |
| 2022 Q3 | 51.9 Billion SEK | 7.07% |
| 2022 FY | 52.03 Billion SEK | 16.78% |
| 2022 Q4 | 52.03 Billion SEK | 0.24% |
| 2022 Q1 | 45.45 Billion SEK | 2.01% |
| 2021 Q1 | 44.83 Billion SEK | -0.41% |
| 2021 Q4 | 44.55 Billion SEK | 2.64% |
| 2021 Q3 | 43.4 Billion SEK | 4.2% |
| 2021 FY | 44.55 Billion SEK | -1.02% |
| 2021 Q2 | 41.66 Billion SEK | -7.07% |
| 2020 Q2 | 49.33 Billion SEK | 2.18% |
| 2020 Q4 | 45.01 Billion SEK | -6.66% |
| 2020 FY | 45.01 Billion SEK | 0.67% |
| 2020 Q1 | 48.28 Billion SEK | 7.99% |
| 2020 Q3 | 48.22 Billion SEK | -2.25% |
| 2019 Q4 | 44.71 Billion SEK | -4.0% |
| 2019 FY | 44.71 Billion SEK | 3.14% |
| 2019 Q3 | 46.57 Billion SEK | 3.34% |
| 2019 Q2 | 45.07 Billion SEK | 0.59% |
| 2019 Q1 | 44.81 Billion SEK | 3.36% |
| 2018 Q2 | 43.46 Billion SEK | 3.36% |
| 2018 Q3 | 42.62 Billion SEK | -1.93% |
| 2018 FY | 43.35 Billion SEK | 2.97% |
| 2018 Q4 | 43.35 Billion SEK | 1.71% |
| 2018 Q1 | 42.05 Billion SEK | -0.12% |
| 2017 Q1 | 54.82 Billion SEK | -0.7% |
| 2017 Q4 | 42.1 Billion SEK | -18.5% |
| 2017 Q3 | 51.65 Billion SEK | -2.24% |
| 2017 Q2 | 52.83 Billion SEK | -3.63% |
| 2017 FY | 42.1 Billion SEK | -23.74% |
| 2016 Q4 | 55.21 Billion SEK | 1.77% |
| 2016 Q3 | 54.25 Billion SEK | 1.3% |
| 2016 Q1 | 52.38 Billion SEK | -1.59% |
| 2016 FY | 55.21 Billion SEK | 3.71% |
| 2016 Q2 | 53.55 Billion SEK | 2.23% |
| 2015 Q1 | 55.55 Billion SEK | 5.19% |
| 2015 FY | 53.23 Billion SEK | 0.79% |
| 2015 Q4 | 53.23 Billion SEK | -0.6% |
| 2015 Q3 | 53.55 Billion SEK | 0.24% |
| 2015 Q2 | 53.43 Billion SEK | -3.83% |
| 2014 Q2 | 46.94 Billion SEK | 3.57% |
| 2014 Q1 | 45.32 Billion SEK | 2.32% |
| 2014 FY | 52.81 Billion SEK | 19.22% |
| 2014 Q4 | 52.81 Billion SEK | 8.47% |
| 2014 Q3 | 48.69 Billion SEK | 3.72% |
| 2013 Q3 | 43.2 Billion SEK | -1.85% |
| 2013 Q2 | 44.02 Billion SEK | 2.71% |
| 2013 Q1 | 42.86 Billion SEK | -0.14% |
| 2013 FY | 44.3 Billion SEK | 3.22% |
| 2013 Q4 | 44.3 Billion SEK | 2.54% |
| 2012 Q1 | 39.85 Billion SEK | -3.9% |
| 2012 Q2 | 41.17 Billion SEK | 3.33% |
| 2012 Q3 | 40.57 Billion SEK | -1.47% |
| 2012 FY | 42.92 Billion SEK | 3.5% |
| 2012 Q4 | 42.92 Billion SEK | 5.78% |
| 2011 Q1 | 33.28 Billion SEK | -3.75% |
| 2011 Q4 | 41.46 Billion SEK | 19.12% |
| 2011 FY | 41.46 Billion SEK | 19.9% |
| 2011 Q3 | 34.81 Billion SEK | 4.42% |
| 2011 Q2 | 33.33 Billion SEK | 0.15% |
| 2010 Q1 | 36.34 Billion SEK | -3.08% |
| 2010 FY | 34.58 Billion SEK | -7.77% |
| 2010 Q4 | 34.58 Billion SEK | -0.02% |
| 2010 Q3 | 34.59 Billion SEK | -7.57% |
| 2010 Q2 | 37.42 Billion SEK | 2.98% |
| 2009 Q4 | 37.49 Billion SEK | 0.0% |
| 2009 FY | 37.49 Billion SEK | 13.52% |
| 2008 FY | 33.03 Billion SEK | 43.67% |
| 2007 FY | 22.99 Billion SEK | 44.81% |
| 2006 FY | 15.87 Billion SEK | 9.25% |
| 2005 FY | 14.53 Billion SEK | 16.66% |
| 2004 FY | 12.45 Billion SEK | 3.53% |
| 2003 FY | 12.03 Billion SEK | 26.95% |
| 2002 FY | 9.47 Billion SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -87520.062% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | -1576.066% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | -1576.066% |
| Arcoma AB | 81.96 Million SEK | -67125.056% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | -7968.645% |
| BICO Group AB (publ) | 10.19 Billion SEK | -440.356% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | -7196.914% |
| CellaVision AB (publ) | 928.71 Million SEK | -5832.84% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -95350.845% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -250857.87% |
| C-Rad AB (publ) | 404 Million SEK | -13538.366% |
| Duearity AB (publ) | 15.14 Million SEK | -363733.862% |
| Dignitana AB (publ) | 44.83 Million SEK | -122803.794% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -52727.421% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -53582.701% |
| Iconovo AB (publ) | 128.07 Million SEK | -42919.245% |
| Integrum AB (publ) | 164.85 Million SEK | -33321.867% |
| Luxbright AB (publ) | 40.68 Million SEK | -135322.768% |
| Mentice AB (publ) | 322.52 Million SEK | -16983.584% |
| OssDsign AB (publ) | 356.38 Million SEK | -15360.354% |
| Paxman AB (publ) | 167.12 Million SEK | -32868.736% |
| Promimic AB (publ) | 92.87 Million SEK | -59225.976% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -141013.046% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -85545.226% |
| ScandiDos AB (publ) | 81.47 Million SEK | -67528.54% |
| Sectra AB (publ) | 3.21 Billion SEK | -1615.978% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | -5333.521% |
| Senzime AB (publ) | 433.54 Million SEK | -12609.034% |
| SpectraCure AB (publ) | 144.83 Million SEK | -37942.863% |
| Stille AB | 804.89 Million SEK | -6745.498% |
| Vitrolife AB (publ) | 16.39 Billion SEK | -236.154% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | -2409.506% |